James Kim

James Kim is a toxicologist in the Office of Information and Regulatory Affairs at the Office of Management and Budget.

Building on 30 Years of Experience to Prepare for the Future of Biotechnology

Summary: EPA, FDA, and USDA unveil two documents as part of the Administration’s continuing effort to modernize the Federal regulatory system for biotechnology products. Today, the Federal government has taken an important step to ensure public confidence in the regulatory system for biotechnology products and to improve the transparency, predictability, coordination, and, ultimately, efficiency of that system. In 1986, the White House Office of Science and Technology Policy (OSTP) issued the Coordinated Framework for the Regulation of Biotechnology, which outlined a comprehensive Federal regulatory policy for ensuring the safety of biotechnology products.

Read More →

Top